Related Experiment Video
Updated: Sep 10, 2025

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
Pulmonary diffusing capacity and dyspnoea following COVID-19: Insights from multicentre datasets
Gerald S Zavorsky1, Giovanni Barisione2, Thomas Gille3
1Department of Physiology and Membrane Biology, University of California Davis, Sacramento, CA, United States.
Abstract:
Pulmonary complications remain a significant challenge for COVID-19 survivors, necessitating advanced diagnostic approaches for long-term assessment. We present a curated, open-access dataset of pulmonary function measurements-including nitric oxide (DLNO) and carbon monoxide (DLCO) diffusing capacities-in 572 post-COVID-19 patients and 72 healthy controls (filtered from an original cohort of 726 survivors and 126 controls). Collected across eight international centres, the data include demographics, spirometry, lung volumes, and 5-6 s single-breath DLNO5s, DLCO5s, and alveolar volume (VA5s). Missing values for total lung capacity were imputed, and low-quality or system-specific (Hyp'Air Compact) measurements were excluded in the filtered dataset. A third subset (333 patients, 54 controls) links these measurements to dyspnoea severity (mMRC scale) for correlation and proportional odds analyses. This resource underpins predictive modeling of post-COVID pulmonary impairment via summed z-scores (DLNO + DLCO) and aims to accelerate validation of NO-CO diagnostics. The freely accessible datasets are provided in both SPSS (.sav) and .csv formats at the Mendeley Data Cloud-based repository and includes nominal, ordinal, and scalar data.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

